← FDA DRUG APPROVALS

FDA ANDA · ANDA088013

ERGOLOID MESYLATES

Sponsor: VANGARD

APPLICATION
ANDA088013
TYPE
ANDA
ORIGINAL APPROVAL
1982-09-20
LATEST ACTION
1982-09-20
ROUTE
SUBLINGUAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ERGOLOID MESYLATESDiscontinued
ERGOLOID MESYLATES 0.5MG · TABLET · SUBLINGUAL

Approval history

1982-09-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →